Acute myeloid leukemia complicated by post COVID-19 multi-system inflammatory syndrome-children

Nalla Anuraag Reddy; Alex Tom; Harsha Prasada Lashkari

doi:10.1016/j.phoj.2021.12.004

Acute myeloid leukemia complicated by post COVID-19 multi-system inflammatory syndrome-children

Nalla Anuraag Reddy
, Alex Tom
, Harsha Prasada Lashkari^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)

Abstract

Corona Virus disease 2019 (COVID-19) pandemic has presented a huge challenge to the health care system in terms of magnitude of cases and to pediatric oncology units with varied clinical presentations. Acute myeloid leukemia(AML) is a rare heterogenous cancer of childhood with an induction mortality around 15% in our country due to neutropenic sepsis. Multisystem inflammatory syndrome in children(MIS-C) is an hyperinflammatory syndrome seen 4–6 weeks after COVID-19 infection. COVID infection in some of these children would have gone unnoticed. Here we report a two year eight months old boy diagnosed with AML on induction chemotherapy developed post COVID MIS-C.

Original language	English
Pages (from-to)	49-51
Number of pages	3
Journal	Pediatric Hematology Oncology Journal
Volume	7
Issue number	2
DOIs	https://doi.org/10.1016/j.phoj.2021.12.004
Publication status	Published - 06-2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

All Science Journal Classification (ASJC) codes

Hematology
Oncology
Pediatrics, Perinatology, and Child Health

Access to Document

10.1016/j.phoj.2021.12.004

Cite this

@article{4b472d590ca7470cb917a222f87e3857,

title = "Acute myeloid leukemia complicated by post COVID-19 multi-system inflammatory syndrome-children",

abstract = "Corona Virus disease 2019 (COVID-19) pandemic has presented a huge challenge to the health care system in terms of magnitude of cases and to pediatric oncology units with varied clinical presentations. Acute myeloid leukemia(AML) is a rare heterogenous cancer of childhood with an induction mortality around 15\% in our country due to neutropenic sepsis. Multisystem inflammatory syndrome in children(MIS-C) is an hyperinflammatory syndrome seen 4–6 weeks after COVID-19 infection. COVID infection in some of these children would have gone unnoticed. Here we report a two year eight months old boy diagnosed with AML on induction chemotherapy developed post COVID MIS-C.",

author = "Reddy, \{Nalla Anuraag\} and Alex Tom and Lashkari, \{Harsha Prasada\}",

note = "Publisher Copyright: {\textcopyright} 2022",

year = "2022",

month = jun,

doi = "10.1016/j.phoj.2021.12.004",

language = "English",

volume = "7",

pages = "49--51",

journal = "Pediatric Hematology Oncology Journal",

issn = "2468-1245",

publisher = "Pediatric Hematology Oncology Chapter of Indian Academy of Pediatrics",

number = "2",

}

TY - JOUR

T1 - Acute myeloid leukemia complicated by post COVID-19 multi-system inflammatory syndrome-children

AU - Reddy, Nalla Anuraag

AU - Tom, Alex

AU - Lashkari, Harsha Prasada

PY - 2022/6

Y1 - 2022/6

N2 - Corona Virus disease 2019 (COVID-19) pandemic has presented a huge challenge to the health care system in terms of magnitude of cases and to pediatric oncology units with varied clinical presentations. Acute myeloid leukemia(AML) is a rare heterogenous cancer of childhood with an induction mortality around 15% in our country due to neutropenic sepsis. Multisystem inflammatory syndrome in children(MIS-C) is an hyperinflammatory syndrome seen 4–6 weeks after COVID-19 infection. COVID infection in some of these children would have gone unnoticed. Here we report a two year eight months old boy diagnosed with AML on induction chemotherapy developed post COVID MIS-C.

AB - Corona Virus disease 2019 (COVID-19) pandemic has presented a huge challenge to the health care system in terms of magnitude of cases and to pediatric oncology units with varied clinical presentations. Acute myeloid leukemia(AML) is a rare heterogenous cancer of childhood with an induction mortality around 15% in our country due to neutropenic sepsis. Multisystem inflammatory syndrome in children(MIS-C) is an hyperinflammatory syndrome seen 4–6 weeks after COVID-19 infection. COVID infection in some of these children would have gone unnoticed. Here we report a two year eight months old boy diagnosed with AML on induction chemotherapy developed post COVID MIS-C.

UR - https://www.scopus.com/pages/publications/85157050432

UR - https://www.scopus.com/pages/publications/85157050432#tab=citedBy

U2 - 10.1016/j.phoj.2021.12.004

DO - 10.1016/j.phoj.2021.12.004

M3 - Article

AN - SCOPUS:85157050432

SN - 2468-1245

VL - 7

SP - 49

EP - 51

JO - Pediatric Hematology Oncology Journal

JF - Pediatric Hematology Oncology Journal

IS - 2

ER -

Acute myeloid leukemia complicated by post COVID-19 multi-system inflammatory syndrome-children

Abstract

UN SDGs

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this